Business
Press Release Jun 05 2026
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 05, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials".
About this update from Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 05, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials". View Attachment
View stock analysis, news, and events for Glenmark Pharmaceuticals Limited